PAINCHEK ORD
PainChek Inks Landmark 20,000-Bed North America Deployment with Sabra Health Care REIT
PainChek inks landmark 20,000-bed North American deployment with Sabra Health Care REIT across 329 facilities, funding beds at $55-75/bed/yr.
PainChek partners with Eldermark Software to expand US market for smartphone pain assessment app
Smartphone pain assessment app developer PainChek (ASX: PCK) has signed a new reseller and integration agreement with Minneapolis-based assisted living provider Eldermark Software to help expand its US market reach. Under the terms of the 12-month rolling agreement, Eldermark will act as a non-exclusive reseller of PainChek’s Adult phone app targeting the US long-term residential […]
PainChek prepares FDA De Novo submission for smartphone app following successful US clinical study
PainChek (ASX: PCK) has announced positive outcomes from a US clinical validation study that will allow the company to progress with a Food and Drug Administration (FDA) De Novo submission for its Adult smartphone app. The study recruited 105 nursing home residents at five sites in Iowa and New York, who were assessed for pain […]
Residential aged care sector drives strong quarterly results for PainChek
Australian medical device company PainChek (ASX: PCK) has reported a strong performance for the March quarter with much of its growth being driven by the country’s residential aged care sector. PainChek’s smartphone-based pain assessment technology was contracted to 49,811 residential aged care and dementia-specific beds during the quarter, representing a 56% increase on the 32,023 […]